Mindray Medical International Limited, founded in 1991 and headquartered in Shenzhen, Guangdong province, is China's largest medical device manufacturer and a leading global supplier of patient monitoring, in-vitro diagnostics, and medical imaging systems. The company's comprehensive product portfolio spans bedside monitors, anesthesia machines, ventilators, ultrasound systems, hematology and chemistry analyzers, and surgical equipment, serving hospitals and clinics across 190 countries. Mindray has built a reputation for delivering high-quality, cost-effective medical equipment that bridges the gap between premium Western brands and budget alternatives, making advanced medical technology accessible to healthcare systems in both developed and emerging markets. The company has been listed on the Shenzhen Stock Exchange's ChiNext board since 2018.

Mindray's competitive strength stems from its R&D intensity—investing approximately 10% of annual revenue in research and development—which has produced a portfolio of over 8,000 patent applications and an expanding pipeline of innovative medical technologies. The company's globalized R&D network with centers in Shenzhen, Beijing, Seattle, and Silicon Valley enables it to combine cost-efficient engineering with access to frontier clinical research and regulatory expertise. In 2025, Mindray published its sustainability report detailing its green manufacturing initiatives, including energy-efficient cleanroom designs and medical device reprocessing programs that extend product lifecycles. The company also expanded its "Healthcare for All" initiative, donating medical equipment and providing clinical training to underserved rural healthcare facilities in China and across Africa and Southeast Asia.

迈瑞医疗国际股份有限公司成立于1991年，总部位于广东深圳，是中国最大的医疗器械制造商，也是全球领先的病人监护、体外诊断和医学影像系统供应商。公司的全面产品组合涵盖床边监护仪、麻醉机、呼吸机、超声系统、血液和化学分析仪以及手术设备，服务于190个国家的医院和诊所。迈瑞以提供高质量、高性价比的医疗设备而建立了声誉，填补了西方高端品牌和低预算替代品之间的空白，使发达和新兴市场的医疗系统都能获得先进的医疗技术。公司自2018年起在深交所创业板上市。

迈瑞医疗的竞争优势源于其研发投入强度——每年将约10%的收入投入研发——产生了超过8,000项专利申请和不断扩展的创新医疗技术管线。公司全球化的研发网络在深圳、北京、西雅图和硅谷设有研发中心，使其能够将高性价比的工程能力与前沿临床研究和监管专业知识相结合。2025年，迈瑞医疗发布了可持续发展报告，详细介绍了其绿色制造计划，包括节能洁净室设计和延长产品生命周期的医疗器械再处理项目。公司还扩展了“健康普惠”计划，向中国以及非洲和东南亚地区资源不足的农村医疗机构捐赠医疗设备并提供临床培训。